View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AH69 | Publication ID: Spring 2018 |
Title: Updating Public Information Regulations | |
Abstract:
FDA is proposing to amend its public information regulations. The proposed amendments bring the agency’s regulations in line with statutory amendments to the FOIA, update cross references to other statutes and parts of the agency’s regulations, and clarify certain provisions with minor editorial updates. Additionally, the rule will update the current regulations to reflect changes to the organization, to make the FOIA process easier for the public to navigate, and to make certain provisions clearer, such as the provisions regarding processing fees. Taken together, these changes will enhance transparency for the public with regard to FDA’s activities. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: Undetermined |
EO 13771 Designation: Deregulatory | |
CFR Citation: 21 CFR 20 | |
Legal Authority: 5 USC 552, sec. 701(a) of the Federal Food, Drug, and Cosmetic Act |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Undetermined |
Federalism: Undetermined | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Sarah Kotler Director, Freedom of Information Department of Health and Human Services Food and Drug Administration 5630 Fishers Lane, Room 1035, Rockville, MD 20857 Phone:301 796-3900 Email: sarah.kotler@fda.hhs.gov |